Nichols Weston: insider trades.
Nichols Weston reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 2 open-market purchases ($79K) and 0 sales, across 2 companies.
- Transactions
- 4
- Purchases (P)
- 2
- Sales (S)
- 0
- Companies
- 2
- Name as filed
- Nichols Weston
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Crinetics Pharmaceuticals, Inc. (CRNX) | Director | 2 |
| Korro Bio, Inc. (KRRO) | TenPercentOwner | 2 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-01 | Crinetics Pharmaceuticals, Inc. | D | 5,925 | $85 | 0 | Form 4 |
| 2026-09-01 | Crinetics Pharmaceuticals, Inc. | D | 16,300 | $85 | 5,925 | Form 4 |
| 2026-08-10 | Korro Bio, Inc. | P | 1,462 | $13.19 | 1,544,980 | Form 4 |
| 2026-08-06 | Korro Bio, Inc. | P | 5,222 | $11.4 | 1,543,518 | Form 4 |
Questions
What stock did Nichols Weston buy or sell?
Nichols Weston reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 2 open-market purchases ($79K) and 0 sales, across 2 companies.
Is Nichols Weston the same person as other filers with this name?
This page covers SEC CIK 1746376 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/nichols-weston-1746376.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.